Evaluation of the Incidence, Severity, and Mortality Rate of COVID-19 in Patients with Multiple Sclerosis Receiving Interferon β-1a Abdorreza Naser Moghadasi Nassim Anjidani DOI: https://doi.org/10.18502/fem.v5i2.5607 Abstract The article's abstract is not available. PDF Published 2021-03-02 Issue Volume 5 issue (2) Section Articles
